HIV Education Series for Primary Care Clinicians with None or Few People Living with HIV (PLHIV) and Those At-risk for HIV
When
This is a Lunch and Learn CME series, sessions are from
12-1:30 P.M. on the following dates:
November 8, 2024
November 15, 2024
November 22, 2024
November 29, 2024
Registration
Description
Are you a family care physician/nurse practitioner with limited experience in managing HIV? Join the HIV Education and Learning (HEaL) series to strengthen your ability to assess, diagnose, and manage patients at risk or living with HIV.
Each session is eligible for Mainpro+1 credit/hour (Approved: College of Family Physicians of Canada)
Audience:
These sessions are for Primary Care, Nurse Practitioners and those treating people with HIV or those at-risk of HIV.
Speakers:
Dr. Charlie Guiang – St. Michael’s Hospital Academic Family Health Team
Dr. Gordon Arbess – St. Michael’s Hospital Academic Family Health Team
Dr. Charlotte Hunter – St. Michael’s Hospital Academic Family Health Team
Dr. James Owen – St. Michael’s Hospital Academic Family Health Team
Date | Topic | Learning Objectives | |
November 8 | HIV and STI Risk Presenters: Dr. Gordon Arbess Dr. Charlie Guiang | At the conclusion of this activity, participants will be able to: 1. Recognize local/Ontario HIV epidemiology. 2. Identify patients at risk for HIV and order HIV testing, applying the 2023 Ontario HIV testing guidelines. 3. Order appropriate STI tests in conjunction with HIV testing. 4. Recognize common late-stage symptoms of HIV infection/AIDs | |
November 15 | HIV Prevention Including PEP and PrEP Presenters: Dr. Charlie Guiang Dr. James Owen | At the conclusion of this session, participants will be able to: 1. Describe the principles of HIV prevention, including risk reduction and behavioral interventions. 2. Explain the use and effectiveness of Pre-Ex6posure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP). | |
November 22 | HIV Testing, Diagnosis and Initial Management Presenters: Dr. Gordon Arbess Dr. Charlie Guiang | At the completion of this session, participants will: 1. Be aware of different HIV testing methods and the interpretation of results. 2. Describe the initial clinical evaluation of a patient newly diagnosed with HIV. 3. Interpret baseline laboratory tests and their significance in HIV management. 4. Explain the principles of antiretroviral therapy (ART) and its impact on HIV progression. 5. Review current ART regimens, including first-line therapies and considerations for treatment selection. | |
November 29 | HIV Special Populations Presenters: Dr. Gordon Arbess Dr. Charlie Guiang Dr. Charlotte Hunter | At the conclusion of this activity, participants will be able to: 1. Identify key HIV risk factors and vulnerabilities specific to women, including socioeconomic, cultural, and biological considerations. 2. Outline the principles of managing clinically stable HIV+ women in primary care, including routine monitoring (e.g., CD4 count, viral load), medication adherence support, and coordination with specialists when necessary. 3. Provide evidence-based guidance on HIV prevention strategies, including Pre-exposure Prophylaxis (PrEP), Post-exposure Prophylaxis (PEP), for women living with HIV. 4. Discuss the integration of sexual and reproductive health services, such as contraception and pregnancy planning, into the care of HIV+ women, with consideration for the unique challenges faced by those in resource-limited settings. 5. Provide an overview of considerations for those co-infected with HIV and Hepatitis C. |